Bonjour,
Quelques informations disponibles sur le site du service de la
pré-qualification de l'OMS et qui peuvent intéresser les acheteurs :
Prequalification Update - 11 November 2009
New WHO Public Inspection Reports (WHOPIRs) published on the
Prequalification Programme web site.
* FPP: Hetero Drugs Limited, Unit-III, Block A and B (25-28 August
2009), Hyderabad - INDIA
<http://apps.who.int/prequal/WHOPIR/WHOPIR_Hetero25-28August2009.pdf> [pdf]
* FPP: Lupin Limited, Rifa and Non-Rifa block N° 2 (29 September-2
October 2009), Aurangabad - INDIA
<http://apps.who.int/prequal/WHOPIR/WHOPIR_Lupin29Sept-2Oct2009.pdf> [pdf]
PQ Update - 11 November 2009 First generic abacavir oral solution
prequalified.
PQ Update - 10 November 2009 Generic indinavir prequalified.
PQ Update - 09 November 2009 Paediatric fixed-dose TB combination
prequalified.
PQ Update - 02 November 2009 GSK's zanamivir (Relenza Rotacaps)
prequalified.
PQ Update - 29 October 2009 First generic ceftriaxone prequalified.
PQ Update - 28 October 2009 New fixed-dose ARV combination prequalified.
PQ Update - 27 October 2009 New WHO Public Assessment Reports (WHOPARs)
published.
PQ Update - 27 October 2009 Matrix' tenofovir prequalified.
PQ Update - 26 October 2009 3 new paediatric ARV formulations
prequalified.
Pour toute information :
http://www.who.int/prequal/query/ProductRegistry.aspx
http://www.who.int/prequal
Carinne Bruneton
ReMeD